Regulation of CD44v6-containing isoforms during proliferation of normal and malignant epithelial cells

Cancer Research

Volumn 57, Issue 11, 1997, Pages 2281-2289

  Soukka, Tero ^c   Salmi, Marko ^c   Joensuu, Heikki ^d   Häkkinen, Lari ^a   Sointu, Petri ^c   Koulu, Leena ^b   Kalimo, Kirsti ^b   Klemi, Pekka ^b   Grénman, Reidar ^b   Jalkanen, Sirpa ^c  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN;

ADULT; AGED; ARTICLE; CELL INTERACTION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; EXON; EXTRACELLULAR MATRIX; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; ULTRAVIOLET B RADIATION;

ADULT; AGED; ANIMALS; ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; DOWN-REGULATION; EPITHELIUM; EXONS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; ISOMERISM; MALE; MICE; MICE, SCID; MIDDLE AGED; SKIN DISEASES; TUMOR CELLS, CULTURED; ULTRAVIOLET RAYS; UP-REGULATION;

EID: 0030974685     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Jalkanen, S., Bargatze, R. F., de los Toyos, J., and Butcher, E. C. Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J. Cell Biol., 105: 983-990, 1987.
2. Oppenheimer-Marks, N., Davis, L. S., and Lipsky, P. E. Human T lymphocyte adhesion to endothelial cells and transendothelial migration. Alteration of receptor use relates to the activation status of both the T cell and the endothelial cell. J. Immunol., 145: 140-148, 1990.
3. Picker, L. J., Nakache, M., and Butcher, E. C. Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types. J. Cell Biol., 709: 927-937, 1989.
4. Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C. B., and Seed, B. CD44 is the principal cell surface receptor for hyaluronate. Cell, 61: 1303-1313, 1990.
5. Carter, W. G., and Wayner, E. A. Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. J. Biol. Chem., 263: 4193-4201, 1988.
6. Jalkanen, S., and Jalkanen, M. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J. Cell Biol., 116: 817-825, 1992.
7. Miyake, K., Underhill, C. B., Lesley, J., and Kincade, P. W. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J. Exp. Med., 172: 69-75, 1990.
8. Belitsos, P. C., Hildreth, J. E. K., and August, J. T. Homotypic cell aggregation induced by anti-CD44(Pgp-1) monoclonal antibodies and related to CD44(Pgp-1) expression. J. Immunol., 144: 1661-1670, 1990.
9. Hale, L. P., Singer, K. H., and Haynes, B. F. CD44 antibody against In(Lu)-related p80, lymphocyte-homing receptor molecule inhibits the binding of human erythrocytes to T cells. J. Immunol., 143: 3944-3948, 1989.
10. Huet, S., Groux, H., Caillou, B., Valentin, H., Pricur, A-M., and Bernard, A. CD44 contributes to T cell activation. J. Immunol., 143: 798-801, 1989.
11. Koopman, G., van Kooyk, Y., de Graaff, M., Meyer, C. J. L. M., Figdor, C. G., and Pals, S. T. Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA-1 pathway. J. Immunol., 145: 3589-3593, 1990.
12. Rothman, B. L., Blue, M-L., Kelley, K. A., Wunderlich, D., Mierz, D. V., and Aune, T. M. Human T cell activation by OKT3 is inhibited by a monoclonal antibody to CD44. J. Immunol., 147: 2493-2499, 1991.
13. MEL-14. Proc. Natl. Acad. Sci. USA, 88: 7877-7881, 1991.
14. Shimizu, Y., van Seventer, G. A., Siraganian, R., Wahl, L., and Shaw, S. Dual role of the CD44 molecule in T cell adhesion and activation. J. Immunol., 143: 2457-2463, 1989.
15. Webb, D. S. A., Shimizu, Y., Van Seventer, G. A., Shaw, S., and Gerrard, T. L. LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF and IL-1 release. Science (Washington DC), 249: 1295-1297, 1990.
16. Jacobson, K., O'Dell, D., Holifield, B., Murphy, T. L., and August, J. T. Redistribution of a major cell surface glycoprotein during cell movement. J. Cell Biol., 99: 1613-1623, 1984.
17. Lazaar, A. L., and Puré, E. CD44: a model for regulated adhesion function. Immunologist, 3: 19-25, 1995.
18. Haynes, B. F., Telen, M. J., Hale, L. P., and Denning, S. M. CD44-a molecule involved in leukocyte adherence and T-cell activation. Immunol. Today, 10: 423-428, 1989.
19. Jalkanen, S., Jalkanen, M., Bargatze, R., Tammi, M., and Butcher, E. C. Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J. Immunol., 141: 1615-1623, 1988.
20. Brown, T. A., Bouchard, T., St. John, T., Wayner, E., and Carter, W. G. Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons. J. Cell Biol., 113: 207-221, 1991.
21. Omary, M. B., Trowbridge, I. S., Letarte, M., Kagnoff, M. F., and Isacke, C. M. Structural heterogeneity of human Pgp-1 and its relationship with p85. Immunogenetics, 27: 460-464, 1988.
22. Screaton, G. R., Bell, M. V., Bell, J. I., and Jackson, D. G. The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. J. Biol. Chem., 268: 12235-12238, 1993.
23. Günthert, U., Hofmann, M., Rudy, W., Reber, S., Zöller, M., Hauβmann, I., Matzku, S., Wenzel, A., Ponta, H., and Herrlich, P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 65: 13-24, 1991.
24. Wielange, V. J. M., Heider, K-H., Offerhaus, G. J. A., Günther, R. A., van der Berg, F. M., Ponta, H., Herrlich, P., and Pals, S. T. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res., 53: 4754-4756, 1993.
25. Kaufmann, M., Heider, K. H., Sinn, H. P., von Minckwitz, G., Ponta, H., and Herrlich, P. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet, 345: 615-619, 1995.
26. Matsumura, Y., and Tarin, D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet, 340: 1053-1058, 1992.
27. Tanabe, K. K., Ellis, L. M., and Saya, H. Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet, 341: 725-726, 1993.
28. Salmi, M., Grön-Virta, K., Sointu, P., Grenman, R., Kalimo, H., and Jalkanen, S. Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. J. Cell Biol., 122: 431-442, 1993.
29. Shanmugaratnam, K., and Sobin, L. H. Histological typing of upper respiratory tract tumors. International Histological Classification of Tumors. Geneva: WHO, 1987.
30. . Hermanek, P., and Sobin, L. H. UICC: TNM Classification of Malignant Tumors, 4th ed. Berlin: Springer-Verlag, 1992.
31. Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A., and Fusenig, N. E. Normal keratinization in a spontaneously immortalized aneuploid keratinocyte cell line. J. Cell Biol., 106: 761-771, 1988.
32. Carey, T. E. Establishment of epidermoid carcinoma cell lines. In: R. E. Wittes (ed.), Head and Neck Cancer, pp. 289-316. London: John Wiley & Sons. 1985.
33. Grenman, R., Pekkola-Heino, K., Joensuu, H., Aitasalo, K., Klemi, P., and Lakkala, T. UT-MUC-1, a new mucoepidermoid carcinoma cell line and its radiation sensitivity. Arch. Otolaryngol. Head & Neck Surg., 118: 542-547, 1992.
34. Kimmel, K. A., and Carey, T. E. Altered expression in squamous cell carcinoma of an orientation restricted epithelial antigen detected by monoclonal antibody A9. Cancer Res., 46: 3614-3623, 1986.
35. Goldstein, A. L., Zhou, D. F. H., Picker, L. J., Minty, C. N., Bargatze, R. F., Ding, J. F., and Butcher, E. C. A human lymphocyte homing receptor, the Hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell, 56: 1063-1072, 1989.
36. Risteli, L., and Timpl, R. Isolation and characterization of pepsin fragments of laminin from human placental and renal basement membranes. Biochem. J., 193: 749-755, 1981.
37. Verrando, P., Hsi, B. L., Yeh, C-J., Pisani, A., Serieys, N., and Ortonne, J-P. Monoclonal antibody GB3, a new probe for the study of human basement membranes and hemidesmosomes. Exp. Cell Res., 170: 116-128, 1987.
38. Stamenkovic, I., Aruffo, A., Amiot, M., and Seed, B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J., 10: 343-348, 1991.
39. He, Q., Lesley, J., Hyman, R., Ishihara, K., and Kincade, P. W. Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition. J. Cell Biol., 119: 1711-1719, 1992.
40. Jackson, D. G., Bell, J. I., Dickinson, R., Timans, J., Shields, J., and Whittle, N. Alternative splicing of an alternative exon V3 generates proteoglycan-like isoforms of the lymph node homing receptor CD44. J. Cell Biol., 128: 673-685, 1995.
41. Liao, H. X., Levesque, M. C., Patton, K., Bergamo, B., Jones, D., Moody, M. A., Telen, M. J., and Haynes, B. F. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies. J. Immunol., 151: 6490-6499, 1993.
42. Lesley, J., English, N., Perschl, A., Gregoroff, J., and Hyman, R. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J. Exp. Med., 182: 431-437, 1995.
43. Bennett, K., Modrell, B., Greenfield, B., Bartolazzi, A., Stamenkovic, I., Peach, R., Jackson, D. G., Spring, F., and Aruffo, A. Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J. Cell Biol., 131: 1623-1633, 1995.
44. Katoh, S., Zheng, Z., Oritani, K., Shimozato, T., and Kincade, P. Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J. Exp. Med., 182: 419-429, 1995.
45. Bennett, K. L., Jackson, D. G., Simon, J. C., Tanczos, E., Peach, R., Modrell, B., Stamenkovic, I., Plowman, G., and Aruffo, A. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J. Cell Biol., 128: 687-698, 1995.
46. Jalkanen, S., Joensuu, H., Söderström, K-O., and Klemi, P. Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma. J. Clin. Invest., 87: 1835-1840, 1991.
47. Stauder, R., Eisterer, W., Thaler, J., and Günthert, U. CD44 variant isoforms in Non-Hodgkin's lymphoma: a new independent prognostic factor. Blood, 85: 2885-2899, 1995.
48. Ristamäki, R., Joensuu, H., Söderström, K-O., and Jalkanen, S. CD44v6 expression in non-Hodgkin's lymphoma: an association with low histological grade and poor prognosis. J. Pathol., 176: 259-267, 1995.
49. Friedrichs, K., Kügler, G., Franke, F., Terpe, H-J., Arlt, J., Regidor, P-A., and Günthert, U. CD44 isoforms in prognosis of breast cancer. Lancet, 345: 1237, 1995.
50. Finke, L. H., Terpe, H-J., Zörb, C., Haensch, W., and Schlag, P. M. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet, 345: 583, 1995.
51. Hudson, D. L., Speight, P. M., and Watt, F. M. Altered expression of CD44 isoforms in squamous-cell carcinomas and cell lines derived from them. Int. J. Cancer, 66: 457-463, 1996.
52. Seelentag, W. K. F., Günthert, U., Saremaslani, P., Futo, E., Pfaltz, M., Heitz, P. U., and Roth, J. CD44 standard and variant isoform expression in human epidermal skin tumors is not correlated with tumor aggressiveness but down-regulated during proliferation and tumor de-differentiation. Int. J. Cancer, 69: 218-224, 1996.
53. Spafford, M. F., Koeppe, J., Pan, Z., Archer, P. G., Meyers, A. D., and Franklin, W. A. Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma. Arch. Otolaryngol. Head & Neck Surg., 122: 627-632, 1996.
54. Hong, R-L., Pu, Y-S., Hsieh, T-S., Chu, J-S., and Lee, W-J. Expressions of E-cadherin and exon v6-containing isoforms of CD44 and their prognostic values in human transitional cell carcinoma, J. Urol., 153: 2025-2028, 1995.
55. Ross, J. S., Delrosario, A. D., Bui, H. X., Kallakury, B. V. S., Okby, N. T., and Figge, J. Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma. Mod. Pathol., 9: 854-860, 1996.
56. Sugino, T., Gorham, H., Yoshida, K., Bolodeoku, J., Nargund, V., Cranston, D., Goodison, S., and Tarin, D. Progressive loss of CD44 gene expression in invasive bladder cancer. Am. J. Pathol., 149: 873-882, 1996.
57. Li, Y-Y., and Cheung, H. T. Basement membrane and its components on lymphocyte adhesion, migration, and proliferation. J. Immunol., 149: 3174-3181, 1992.
58. Pekkola-Heino, K., Kulmala, J., Lakkala, T., Aitasalo, K., Joensuu. H., and Grenman, R. Effects of radiation fractionation on four squamous cell carcinoma lines with dissimilar inherent radiation sensitivity. J. Cancer Res. Clin. Oncol., 117: 597-602, 1991.
59. Grenman, R., Carey, T. E., McClatchey, K. D., Wagner, J. G., Pekkola-Heino, K., Schwartz, M. S., Wolf, G. T., Lacivita, L. P., Ho, L., Baker, S. R., Krause, C. J., and Lichter. A. S. In vitro radiation resistance among cell lines established from patients with squamous cell carcinoma of the head and neck. Cancer (Phila.), 67: 2741-2747, 1991.
60. Pekkola-Heino, K., Kulmala, J., and Grenman, R. Sublethal damage repair in squamous cell carcinoma cell lines. Head & Neck, 14: 196-199, 1992.
61. Pekkola-Heino, K., Joensuu, H., Klemi, P., and Grenman, R. Relation of DNA ploidy and proliferation rate to radiation sensitivity in squamous cell carcinoma. Arch. Otolaryngol. Head & Neck Surg., 120: 750-754, 1994.